HEADER SIGNALING PROTEIN/IMMUNE SYSTEM 13-JUL-23 8TH4 TITLE STRUCTURE OF AT118-L NANOBODY ANTAGONIST IN COMPLEX WITH THE TITLE 2 ANGIOTENSIN II TYPE I RECEPTOR AND LOSARTAN COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYPE-1 ANGIOTENSIN II RECEPTOR SOLUBLE CYTOCHROME B562 COMPND 3 COMPLEX; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: AT1AR,AT1BR,ANGIOTENSIN II TYPE-1 RECEPTOR,AT1 RECEPTOR, COMPND 6 CYTOCHROME B-562; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: BAG2 ANTI-BRIL FAB HEAVY CHAIN; COMPND 10 CHAIN: C; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: BAG2 ANTI-BRIL FAB LIGHT CHAIN; COMPND 14 CHAIN: D; COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 4; COMPND 17 MOLECULE: AT118-L NANOBODY; COMPND 18 CHAIN: B; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ESCHERICHIA COLI; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 562; SOURCE 5 GENE: AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B, CYBC; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL: EXPI293 TET-R; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 12 ORGANISM_TAXID: 32630; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 16 MOL_ID: 3; SOURCE 17 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 18 ORGANISM_TAXID: 32630; SOURCE 19 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 20 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 22 MOL_ID: 4; SOURCE 23 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 24 ORGANISM_TAXID: 32630; SOURCE 25 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 26 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS G PROTEIN-COUPLED RECEPTOR, NANOBODY, SIGNALING PROTEIN-IMMUNE SYSTEM KEYWDS 2 COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR M.A.SKIBA,A.C.KRUSE REVDAT 4 04-DEC-24 8TH4 1 JRNL REVDAT 3 06-NOV-24 8TH4 1 REMARK REVDAT 2 29-MAY-24 8TH4 1 JRNL REVDAT 1 22-MAY-24 8TH4 0 JRNL AUTH M.A.SKIBA,S.M.STERLING,S.RAWSON,S.ZHANG,H.XU,H.JIANG, JRNL AUTH 2 G.R.NEMETH,M.S.A.GILMAN,J.D.HURLEY,P.SHEN,D.P.STAUS,J.KIM, JRNL AUTH 3 C.MCMAHON,M.K.LEHTINEN,H.A.ROCKMAN,P.BARTH,L.M.WINGLER, JRNL AUTH 4 A.C.KRUSE JRNL TITL ANTIBODIES EXPAND THE SCOPE OF ANGIOTENSIN RECEPTOR JRNL TITL 2 PHARMACOLOGY. JRNL REF NAT.CHEM.BIOL. V. 20 1577 2024 JRNL REFN ESSN 1552-4469 JRNL PMID 38744986 JRNL DOI 10.1038/S41589-024-01620-6 REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, SERIALEM, CRYOSPARC, REMARK 3 CRYOSPARC, CRYOSPARC, CRYOSPARC, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.300 REMARK 3 NUMBER OF PARTICLES : 238621 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8TH4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1000275920. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : AT118-L NANOBODY ANTAGONIST IN REMARK 245 COMPLEX WITH THE ANGIOTENSIN II REMARK 245 TYPE I RECEPTOR BRIL FUSION REMARK 245 PROTEIN, ANTI-BRIL FAB, ANTI- REMARK 245 FAB NANOBODY, AND LOSARTAN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 7.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1800.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6410.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A -6 REMARK 465 TYR A -5 REMARK 465 LYS A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 ASP A -1 REMARK 465 ASP A 0 REMARK 465 LYS A 1 REMARK 465 ILE A 2 REMARK 465 LEU A 3 REMARK 465 ASN A 4 REMARK 465 SER A 5 REMARK 465 SER A 6 REMARK 465 THR A 7 REMARK 465 GLU A 8 REMARK 465 ASP A 9 REMARK 465 GLY A 10 REMARK 465 ILE A 11 REMARK 465 LYS A 12 REMARK 465 ARG A 13 REMARK 465 ILE A 14 REMARK 465 GLN A 15 REMARK 465 ASP A 16 REMARK 465 ASP A 17 REMARK 465 CYS A 18 REMARK 465 PRO A 19 REMARK 465 LYS A 20 REMARK 465 LYS A 135 REMARK 465 SER A 136 REMARK 465 ARG A 137 REMARK 465 LEU A 138 REMARK 465 ARG A 139 REMARK 465 PRO A 271 REMARK 465 LYS A 272 REMARK 465 LEU A 273 REMARK 465 GLU A 274 REMARK 465 ASP A 275 REMARK 465 LYS A 276 REMARK 465 SER A 277 REMARK 465 PRO A 278 REMARK 465 ASP A 279 REMARK 465 SER A 280 REMARK 465 PRO A 281 REMARK 465 GLU A 282 REMARK 465 PHE A 1313 REMARK 465 LEU A 1314 REMARK 465 GLN A 1315 REMARK 465 LEU A 1316 REMARK 465 LEU A 1317 REMARK 465 LYS A 1318 REMARK 465 TYR A 1319 REMARK 465 GLU C 1 REMARK 465 ILE C 2 REMARK 465 SER C 3 REMARK 465 SER C 126 REMARK 465 SER C 127 REMARK 465 ALA C 128 REMARK 465 SER C 129 REMARK 465 THR C 130 REMARK 465 LYS C 131 REMARK 465 GLY C 132 REMARK 465 PRO C 133 REMARK 465 SER C 134 REMARK 465 VAL C 135 REMARK 465 PHE C 136 REMARK 465 PRO C 137 REMARK 465 LEU C 138 REMARK 465 ALA C 139 REMARK 465 PRO C 140 REMARK 465 SER C 141 REMARK 465 SER C 142 REMARK 465 LYS C 143 REMARK 465 SER C 144 REMARK 465 THR C 145 REMARK 465 SER C 146 REMARK 465 GLY C 147 REMARK 465 GLY C 148 REMARK 465 THR C 149 REMARK 465 ALA C 150 REMARK 465 ALA C 151 REMARK 465 LEU C 152 REMARK 465 GLY C 153 REMARK 465 CYS C 154 REMARK 465 LEU C 155 REMARK 465 VAL C 156 REMARK 465 LYS C 157 REMARK 465 ASP C 158 REMARK 465 TYR C 159 REMARK 465 PHE C 160 REMARK 465 PRO C 161 REMARK 465 GLU C 162 REMARK 465 PRO C 163 REMARK 465 VAL C 164 REMARK 465 THR C 165 REMARK 465 VAL C 166 REMARK 465 SER C 167 REMARK 465 TRP C 168 REMARK 465 ASN C 169 REMARK 465 SER C 170 REMARK 465 GLY C 171 REMARK 465 ALA C 172 REMARK 465 LEU C 173 REMARK 465 THR C 174 REMARK 465 SER C 175 REMARK 465 GLY C 176 REMARK 465 VAL C 177 REMARK 465 HIS C 178 REMARK 465 THR C 179 REMARK 465 PHE C 180 REMARK 465 PRO C 181 REMARK 465 ALA C 182 REMARK 465 VAL C 183 REMARK 465 LEU C 184 REMARK 465 GLN C 185 REMARK 465 SER C 186 REMARK 465 SER C 187 REMARK 465 GLY C 188 REMARK 465 LEU C 189 REMARK 465 TYR C 190 REMARK 465 SER C 191 REMARK 465 LEU C 192 REMARK 465 SER C 193 REMARK 465 SER C 194 REMARK 465 VAL C 195 REMARK 465 VAL C 196 REMARK 465 THR C 197 REMARK 465 VAL C 198 REMARK 465 PRO C 199 REMARK 465 SER C 200 REMARK 465 SER C 201 REMARK 465 SER C 202 REMARK 465 LEU C 203 REMARK 465 GLY C 204 REMARK 465 THR C 205 REMARK 465 GLN C 206 REMARK 465 THR C 207 REMARK 465 TYR C 208 REMARK 465 ILE C 209 REMARK 465 CYS C 210 REMARK 465 ASN C 211 REMARK 465 VAL C 212 REMARK 465 ASN C 213 REMARK 465 HIS C 214 REMARK 465 LYS C 215 REMARK 465 PRO C 216 REMARK 465 SER C 217 REMARK 465 ASN C 218 REMARK 465 THR C 219 REMARK 465 LYS C 220 REMARK 465 VAL C 221 REMARK 465 ASP C 222 REMARK 465 LYS C 223 REMARK 465 LYS C 224 REMARK 465 VAL C 225 REMARK 465 GLU C 226 REMARK 465 PRO C 227 REMARK 465 LYS C 228 REMARK 465 SER C 229 REMARK 465 CYS C 230 REMARK 465 ASP C 231 REMARK 465 ILE D 108 REMARK 465 LYS D 109 REMARK 465 ARG D 110 REMARK 465 THR D 111 REMARK 465 VAL D 112 REMARK 465 ALA D 113 REMARK 465 ALA D 114 REMARK 465 PRO D 115 REMARK 465 SER D 116 REMARK 465 VAL D 117 REMARK 465 PHE D 118 REMARK 465 ILE D 119 REMARK 465 PHE D 120 REMARK 465 PRO D 121 REMARK 465 PRO D 122 REMARK 465 SER D 123 REMARK 465 ASP D 124 REMARK 465 GLU D 125 REMARK 465 GLN D 126 REMARK 465 LEU D 127 REMARK 465 LYS D 128 REMARK 465 SER D 129 REMARK 465 GLY D 130 REMARK 465 THR D 131 REMARK 465 ALA D 132 REMARK 465 SER D 133 REMARK 465 VAL D 134 REMARK 465 VAL D 135 REMARK 465 CYS D 136 REMARK 465 LEU D 137 REMARK 465 LEU D 138 REMARK 465 ASN D 139 REMARK 465 ASN D 140 REMARK 465 PHE D 141 REMARK 465 TYR D 142 REMARK 465 PRO D 143 REMARK 465 ARG D 144 REMARK 465 GLU D 145 REMARK 465 ALA D 146 REMARK 465 LYS D 147 REMARK 465 VAL D 148 REMARK 465 GLN D 149 REMARK 465 TRP D 150 REMARK 465 LYS D 151 REMARK 465 VAL D 152 REMARK 465 ASP D 153 REMARK 465 ASN D 154 REMARK 465 ALA D 155 REMARK 465 LEU D 156 REMARK 465 GLN D 157 REMARK 465 SER D 158 REMARK 465 GLY D 159 REMARK 465 ASN D 160 REMARK 465 SER D 161 REMARK 465 GLN D 162 REMARK 465 GLU D 163 REMARK 465 SER D 164 REMARK 465 VAL D 165 REMARK 465 THR D 166 REMARK 465 GLU D 167 REMARK 465 GLN D 168 REMARK 465 ASP D 169 REMARK 465 SER D 170 REMARK 465 LYS D 171 REMARK 465 ASP D 172 REMARK 465 SER D 173 REMARK 465 THR D 174 REMARK 465 TYR D 175 REMARK 465 SER D 176 REMARK 465 LEU D 177 REMARK 465 SER D 178 REMARK 465 SER D 179 REMARK 465 THR D 180 REMARK 465 LEU D 181 REMARK 465 THR D 182 REMARK 465 LEU D 183 REMARK 465 SER D 184 REMARK 465 LYS D 185 REMARK 465 ALA D 186 REMARK 465 ASP D 187 REMARK 465 TYR D 188 REMARK 465 GLU D 189 REMARK 465 LYS D 190 REMARK 465 HIS D 191 REMARK 465 LYS D 192 REMARK 465 VAL D 193 REMARK 465 TYR D 194 REMARK 465 ALA D 195 REMARK 465 CYS D 196 REMARK 465 GLU D 197 REMARK 465 VAL D 198 REMARK 465 THR D 199 REMARK 465 HIS D 200 REMARK 465 GLN D 201 REMARK 465 GLY D 202 REMARK 465 LEU D 203 REMARK 465 SER D 204 REMARK 465 SER D 205 REMARK 465 PRO D 206 REMARK 465 VAL D 207 REMARK 465 THR D 208 REMARK 465 LYS D 209 REMARK 465 SER D 210 REMARK 465 PHE D 211 REMARK 465 ASN D 212 REMARK 465 ARG D 213 REMARK 465 GLY D 214 REMARK 465 GLU D 215 REMARK 465 CYS D 216 REMARK 465 GLU B 1 REMARK 465 VAL B 2 REMARK 465 GLN B 3 REMARK 465 VAL B 116 REMARK 465 SER B 117 REMARK 465 SER B 118 REMARK 465 GLY B 119 REMARK 465 LYS B 120 REMARK 465 PRO B 121 REMARK 465 ILE B 122 REMARK 465 PRO B 123 REMARK 465 ASN B 124 REMARK 465 PRO B 125 REMARK 465 LEU B 126 REMARK 465 LEU B 127 REMARK 465 GLY B 128 REMARK 465 LEU B 129 REMARK 465 ASP B 130 REMARK 465 SER B 131 REMARK 465 THR B 132 REMARK 465 LEU B 133 REMARK 465 GLU B 134 REMARK 465 HIS B 135 REMARK 465 HIS B 136 REMARK 465 HIS B 137 REMARK 465 HIS B 138 REMARK 465 HIS B 139 REMARK 465 HIS B 140 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 58 CG CD CE NZ REMARK 470 VAL C 125 CG1 CG2 REMARK 470 GLN B 13 CG CD OE1 NE2 REMARK 470 SER B 84 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 58 18.76 59.75 REMARK 500 TRP A 94 107.89 -48.49 REMARK 500 GLU A 173 -150.46 56.77 REMARK 500 ALA A 248 -1.38 65.93 REMARK 500 VAL C 51 -62.76 -120.72 REMARK 500 ALA C 113 -158.71 55.67 REMARK 500 SER D 31 -134.95 57.03 REMARK 500 ALA D 52 -6.51 71.53 REMARK 500 SER D 53 -2.79 -141.55 REMARK 500 ASP D 83 51.63 -92.73 REMARK 500 ALA B 50 143.98 -170.69 REMARK 500 ASP B 72 117.24 -160.52 REMARK 500 SER B 74 -60.10 -90.75 REMARK 500 ALA B 87 -136.48 59.15 REMARK 500 GLU B 88 30.20 -98.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-41249 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-41248 RELATED DB: EMDB DBREF 8TH4 A 2 226 UNP P30556 AGTR1_HUMAN 2 226 DBREF 8TH4 A 227 330 UNP P0ABE7 C562_ECOLX 24 127 DBREF 8TH4 A 1235 1319 UNP P30556 AGTR1_HUMAN 235 319 DBREF 8TH4 C 1 231 PDB 8TH4 8TH4 1 231 DBREF 8TH4 D 2 216 PDB 8TH4 8TH4 2 216 DBREF 8TH4 B 1 140 PDB 8TH4 8TH4 1 140 SEQADV 8TH4 ASP A -6 UNP P30556 EXPRESSION TAG SEQADV 8TH4 TYR A -5 UNP P30556 EXPRESSION TAG SEQADV 8TH4 LYS A -4 UNP P30556 EXPRESSION TAG SEQADV 8TH4 ASP A -3 UNP P30556 EXPRESSION TAG SEQADV 8TH4 ASP A -2 UNP P30556 EXPRESSION TAG SEQADV 8TH4 ASP A -1 UNP P30556 EXPRESSION TAG SEQADV 8TH4 ASP A 0 UNP P30556 EXPRESSION TAG SEQADV 8TH4 LYS A 1 UNP P30556 EXPRESSION TAG SEQADV 8TH4 TRP A 232 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 8TH4 ILE A 327 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 8TH4 LEU A 331 UNP P0ABE7 LINKER SEQADV 8TH4 GLU A 332 UNP P0ABE7 LINKER SEQADV 8TH4 ARG A 333 UNP P0ABE7 LINKER SEQADV 8TH4 ALA A 334 UNP P0ABE7 LINKER SEQADV 8TH4 ARG A 335 UNP P0ABE7 LINKER SEQADV 8TH4 SER A 336 UNP P0ABE7 LINKER SEQADV 8TH4 THR A 337 UNP P0ABE7 LINKER SEQADV 8TH4 LEU A 338 UNP P0ABE7 LINKER SEQADV 8TH4 ASP A 339 UNP P0ABE7 LINKER SEQADV 8TH4 LYS A 340 UNP P0ABE7 LINKER SEQADV 8TH4 LEU A 341 UNP P0ABE7 LINKER SEQRES 1 A 433 ASP TYR LYS ASP ASP ASP ASP LYS ILE LEU ASN SER SER SEQRES 2 A 433 THR GLU ASP GLY ILE LYS ARG ILE GLN ASP ASP CYS PRO SEQRES 3 A 433 LYS ALA GLY ARG HIS ASN TYR ILE PHE VAL MET ILE PRO SEQRES 4 A 433 THR LEU TYR SER ILE ILE PHE VAL VAL GLY ILE PHE GLY SEQRES 5 A 433 ASN SER LEU VAL VAL ILE VAL ILE TYR PHE TYR MET LYS SEQRES 6 A 433 LEU LYS THR VAL ALA SER VAL PHE LEU LEU ASN LEU ALA SEQRES 7 A 433 LEU ALA ASP LEU CYS PHE LEU LEU THR LEU PRO LEU TRP SEQRES 8 A 433 ALA VAL TYR THR ALA MET GLU TYR ARG TRP PRO PHE GLY SEQRES 9 A 433 ASN TYR LEU CYS LYS ILE ALA SER ALA SER VAL SER PHE SEQRES 10 A 433 ASN LEU TYR ALA SER VAL PHE LEU LEU THR CYS LEU SER SEQRES 11 A 433 ILE ASP ARG TYR LEU ALA ILE VAL HIS PRO MET LYS SER SEQRES 12 A 433 ARG LEU ARG ARG THR MET LEU VAL ALA LYS VAL THR CYS SEQRES 13 A 433 ILE ILE ILE TRP LEU LEU ALA GLY LEU ALA SER LEU PRO SEQRES 14 A 433 ALA ILE ILE HIS ARG ASN VAL PHE PHE ILE GLU ASN THR SEQRES 15 A 433 ASN ILE THR VAL CYS ALA PHE HIS TYR GLU SER GLN ASN SEQRES 16 A 433 SER THR LEU PRO ILE GLY LEU GLY LEU THR LYS ASN ILE SEQRES 17 A 433 LEU GLY PHE LEU PHE PRO PHE LEU ILE ILE LEU THR SER SEQRES 18 A 433 TYR THR LEU ILE TRP LYS ALA LEU LYS LYS ALA TYR ASP SEQRES 19 A 433 LEU GLU ASP ASN TRP GLU THR LEU ASN ASP ASN LEU LYS SEQRES 20 A 433 VAL ILE GLU LYS ALA ASP ASN ALA ALA GLN VAL LYS ASP SEQRES 21 A 433 ALA LEU THR LYS MET ARG ALA ALA ALA LEU ASP ALA GLN SEQRES 22 A 433 LYS ALA THR PRO PRO LYS LEU GLU ASP LYS SER PRO ASP SEQRES 23 A 433 SER PRO GLU MET LYS ASP PHE ARG HIS GLY PHE ASP ILE SEQRES 24 A 433 LEU VAL GLY GLN ILE ASP ASP ALA LEU LYS LEU ALA ASN SEQRES 25 A 433 GLU GLY LYS VAL LYS GLU ALA GLN ALA ALA ALA GLU GLN SEQRES 26 A 433 LEU LYS THR THR ARG ASN ALA TYR ILE GLN LYS TYR LEU SEQRES 27 A 433 GLU ARG ALA ARG SER THR LEU ASP LYS LEU ASN ASP ASP SEQRES 28 A 433 ILE PHE LYS ILE ILE MET ALA ILE VAL LEU PHE PHE PHE SEQRES 29 A 433 PHE SER TRP ILE PRO HIS GLN ILE PHE THR PHE LEU ASP SEQRES 30 A 433 VAL LEU ILE GLN LEU GLY ILE ILE ARG ASP CYS ARG ILE SEQRES 31 A 433 ALA ASP ILE VAL ASP THR ALA MET PRO ILE THR ILE CYS SEQRES 32 A 433 ILE ALA TYR PHE ASN ASN CYS LEU ASN PRO LEU PHE TYR SEQRES 33 A 433 GLY PHE LEU GLY LYS LYS PHE LYS ARG TYR PHE LEU GLN SEQRES 34 A 433 LEU LEU LYS TYR SEQRES 1 C 231 GLU ILE SER GLU VAL GLN LEU VAL GLU SER GLY GLY GLY SEQRES 2 C 231 LEU VAL GLN PRO GLY GLY SER LEU ARG LEU SER CYS ALA SEQRES 3 C 231 ALA SER GLY PHE ASN VAL VAL ASP PHE SER LEU HIS TRP SEQRES 4 C 231 VAL ARG GLN ALA PRO GLY LYS GLY LEU GLU TRP VAL ALA SEQRES 5 C 231 TYR ILE SER SER SER SER GLY SER THR SER TYR ALA ASP SEQRES 6 C 231 SER VAL LYS GLY ARG PHE THR ILE SER ALA ASP THR SER SEQRES 7 C 231 LYS ASN THR ALA TYR LEU GLN MET ASN SER LEU ARG ALA SEQRES 8 C 231 GLU ASP THR ALA VAL TYR TYR CYS ALA ARG TRP GLY TYR SEQRES 9 C 231 TRP PRO GLY GLU PRO TRP TRP LYS ALA PHE ASP TYR TRP SEQRES 10 C 231 GLY GLN GLY THR LEU VAL THR VAL SER SER ALA SER THR SEQRES 11 C 231 LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SER SER LYS SEQRES 12 C 231 SER THR SER GLY GLY THR ALA ALA LEU GLY CYS LEU VAL SEQRES 13 C 231 LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SER TRP ASN SEQRES 14 C 231 SER GLY ALA LEU THR SER GLY VAL HIS THR PHE PRO ALA SEQRES 15 C 231 VAL LEU GLN SER SER GLY LEU TYR SER LEU SER SER VAL SEQRES 16 C 231 VAL THR VAL PRO SER SER SER LEU GLY THR GLN THR TYR SEQRES 17 C 231 ILE CYS ASN VAL ASN HIS LYS PRO SER ASN THR LYS VAL SEQRES 18 C 231 ASP LYS LYS VAL GLU PRO LYS SER CYS ASP SEQRES 1 D 215 ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 D 215 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SER SEQRES 3 D 215 GLN SER VAL SER SER ALA VAL ALA TRP TYR GLN GLN LYS SEQRES 4 D 215 PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR SER ALA SER SEQRES 5 D 215 SER LEU TYR SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 D 215 ARG SER GLY THR ASP PHE THR LEU THR ILE SER SER LEU SEQRES 7 D 215 GLN PRO GLU ASP PHE ALA THR TYR TYR CYS GLN GLN TYR SEQRES 8 D 215 LEU TYR TYR SER LEU VAL THR PHE GLY GLN GLY THR LYS SEQRES 9 D 215 VAL GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE SEQRES 10 D 215 ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR SEQRES 11 D 215 ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG SEQRES 12 D 215 GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SEQRES 13 D 215 SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER SEQRES 14 D 215 LYS ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SEQRES 15 D 215 SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS SEQRES 16 D 215 GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SEQRES 17 D 215 SER PHE ASN ARG GLY GLU CYS SEQRES 1 B 140 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 B 140 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 B 140 TYR ILE TYR SER ARG TYR ARG MET GLY TRP TYR ARG GLN SEQRES 4 B 140 ALA PRO GLY LYS GLY ARG GLU PHE VAL ALA ALA ILE SER SEQRES 5 B 140 GLY GLY SER SER THR ASN TYR ALA ASP SER VAL LYS GLY SEQRES 6 B 140 ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR VAL SEQRES 7 B 140 TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR ALA SEQRES 8 B 140 VAL TYR TYR CYS ALA ALA TYR LYS ILE ASP SER ASN PRO SEQRES 9 B 140 ARG VAL TYR TRP GLY GLN GLY THR GLN VAL THR VAL SER SEQRES 10 B 140 SER GLY LYS PRO ILE PRO ASN PRO LEU LEU GLY LEU ASP SEQRES 11 B 140 SER THR LEU GLU HIS HIS HIS HIS HIS HIS HET LSN A1401 30 HETNAM LSN [2-BUTYL-5-CHLORANYL-3-[[4-[2-(2H-1,2,3,4-TETRAZOL-5- HETNAM 2 LSN YL)PHENYL]PHENYL]METHYL]IMIDAZOL-4-YL]METHANOL HETSYN LSN LOSARTAN FORMUL 5 LSN C22 H23 CL N6 O HELIX 1 AA1 ARG A 23 VAL A 29 1 7 HELIX 2 AA2 MET A 30 TYR A 56 1 27 HELIX 3 AA3 THR A 61 MET A 90 1 30 HELIX 4 AA4 GLY A 97 HIS A 132 1 36 HELIX 5 AA5 THR A 141 SER A 160 1 20 HELIX 6 AA6 SER A 160 HIS A 166 1 7 HELIX 7 AA7 THR A 190 GLY A 203 1 14 HELIX 8 AA8 PHE A 204 ALA A 245 1 42 HELIX 9 AA9 ALA A 249 LYS A 267 1 19 HELIX 10 AB1 LYS A 284 GLY A 307 1 24 HELIX 11 AB2 LYS A 308 ILE A 327 1 20 HELIX 12 AB3 ILE A 327 LYS A 340 1 14 HELIX 13 AB4 ASP A 1236 TRP A 1253 1 18 HELIX 14 AB5 TRP A 1253 LEU A 1268 1 16 HELIX 15 AB6 ASP A 1273 TYR A 1292 1 20 HELIX 16 AB7 PHE A 1293 ASN A 1298 5 6 HELIX 17 AB8 PRO A 1299 GLY A 1306 1 8 HELIX 18 AB9 GLY A 1306 TYR A 1312 1 7 HELIX 19 AC1 ASN C 31 ASP C 34 5 4 HELIX 20 AC2 SER B 25 ARG B 31 1 7 SHEET 1 AA1 7 ARG A 167 PHE A 171 0 SHEET 2 AA1 7 THR A 178 TYR A 184 -1 O VAL A 179 N PHE A 170 SHEET 3 AA1 7 ARG B 105 TYR B 107 1 O VAL B 106 N PHE A 182 SHEET 4 AA1 7 ALA B 91 LYS B 99 -1 N LYS B 99 O ARG B 105 SHEET 5 AA1 7 ARG B 33 GLN B 39 -1 N GLY B 35 O ALA B 96 SHEET 6 AA1 7 ARG B 45 ALA B 50 -1 O VAL B 48 N TRP B 36 SHEET 7 AA1 7 ASN B 58 TYR B 59 -1 O ASN B 58 N ALA B 50 SHEET 1 AA2 5 ARG A 167 PHE A 171 0 SHEET 2 AA2 5 THR A 178 TYR A 184 -1 O VAL A 179 N PHE A 170 SHEET 3 AA2 5 ARG B 105 TYR B 107 1 O VAL B 106 N PHE A 182 SHEET 4 AA2 5 ALA B 91 LYS B 99 -1 N LYS B 99 O ARG B 105 SHEET 5 AA2 5 THR B 112 VAL B 114 -1 O VAL B 114 N ALA B 91 SHEET 1 AA3 4 GLN C 6 SER C 10 0 SHEET 2 AA3 4 SER C 24 SER C 28 -1 O ALA C 26 N VAL C 8 SHEET 3 AA3 4 THR C 81 GLN C 85 -1 O ALA C 82 N CYS C 25 SHEET 4 AA3 4 THR C 72 ASP C 76 -1 N THR C 72 O GLN C 85 SHEET 1 AA4 6 GLY C 13 LEU C 14 0 SHEET 2 AA4 6 THR C 121 THR C 124 1 O THR C 124 N GLY C 13 SHEET 3 AA4 6 ALA C 95 TRP C 102 -1 N TYR C 97 O THR C 121 SHEET 4 AA4 6 SER C 36 GLN C 42 -1 N VAL C 40 O TYR C 98 SHEET 5 AA4 6 LEU C 48 SER C 55 -1 O GLU C 49 N ARG C 41 SHEET 6 AA4 6 SER C 60 TYR C 63 -1 O SER C 60 N SER C 55 SHEET 1 AA5 4 MET D 5 GLN D 7 0 SHEET 2 AA5 4 VAL D 20 ALA D 26 -1 O ARG D 25 N THR D 6 SHEET 3 AA5 4 ASP D 71 ILE D 76 -1 O PHE D 72 N CYS D 24 SHEET 4 AA5 4 PHE D 63 SER D 68 -1 N SER D 64 O THR D 75 SHEET 1 AA6 5 SER D 54 LEU D 55 0 SHEET 2 AA6 5 LYS D 46 TYR D 50 -1 N TYR D 50 O SER D 54 SHEET 3 AA6 5 VAL D 34 GLN D 39 -1 N TRP D 36 O LEU D 48 SHEET 4 AA6 5 THR D 86 GLN D 91 -1 O THR D 86 N GLN D 39 SHEET 5 AA6 5 THR D 99 PHE D 100 -1 O THR D 99 N GLN D 91 SHEET 1 AA7 5 SER D 54 LEU D 55 0 SHEET 2 AA7 5 LYS D 46 TYR D 50 -1 N TYR D 50 O SER D 54 SHEET 3 AA7 5 VAL D 34 GLN D 39 -1 N TRP D 36 O LEU D 48 SHEET 4 AA7 5 THR D 86 GLN D 91 -1 O THR D 86 N GLN D 39 SHEET 5 AA7 5 THR D 104 LYS D 105 -1 O THR D 104 N TYR D 87 SHEET 1 AA8 3 ARG B 19 ALA B 23 0 SHEET 2 AA8 3 THR B 77 MET B 82 -1 O LEU B 80 N LEU B 20 SHEET 3 AA8 3 PHE B 67 ASP B 72 -1 N SER B 70 O TYR B 79 SSBOND 1 CYS A 101 CYS A 180 1555 1555 2.03 SSBOND 2 CYS C 25 CYS C 99 1555 1555 2.03 SSBOND 3 CYS D 24 CYS D 89 1555 1555 2.03 SSBOND 4 CYS B 22 CYS B 95 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000